Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Organogenesis Holdings (ORGO) Change in Cash (2016 - 2025)

Historic Change in Cash for Organogenesis Holdings (ORGO) over the last 10 years, with Q3 2025 value amounting to -$9.4 million.

  • Organogenesis Holdings' Change in Cash fell 31045.18% to -$9.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$30.6 million, marking a year-over-year decrease of 68363.68%. This contributed to the annual value of $31.8 million for FY2024, which is 293559.16% up from last year.
  • According to the latest figures from Q3 2025, Organogenesis Holdings' Change in Cash is -$9.4 million, which was down 31045.18% from -$36.8 million recorded in Q2 2025.
  • Organogenesis Holdings' Change in Cash's 5-year high stood at $41.2 million during Q4 2024, with a 5-year trough of -$36.8 million in Q2 2025.
  • For the 5-year period, Organogenesis Holdings' Change in Cash averaged around -$1.1 million, with its median value being $93000.0 (2023).
  • Its Change in Cash has fluctuated over the past 5 years, first soared by 111612.9% in 2024, then plummeted by 335366.93% in 2025.
  • Organogenesis Holdings' Change in Cash (Quarter) stood at $11.8 million in 2021, then plummeted by 140.08% to -$4.7 million in 2022, then skyrocketed by 216.53% to $5.5 million in 2023, then soared by 647.78% to $41.2 million in 2024, then plummeted by 122.71% to -$9.4 million in 2025.
  • Its last three reported values are -$9.4 million in Q3 2025, -$36.8 million for Q2 2025, and -$25.6 million during Q1 2025.